Pharmacotherapy for the management of obesity

Metabolism: Clinical and Experimental
Dhiren Patel

Abstract

In the last 30 years, obesity has rapidly increased and obesity-related comorbidities have surged. Once considered to be a problem only in developed nations, obesity has become a global epidemic. Consequently, the costs associated with managing overweight and obesity worldwide are astronomical. The objective of this mini-review is to provide an overview of current options available for obesity management, with a focus on anti-obesity pharmacotherapies. The impact of weight loss on improving obesity-related comorbidities and risk factors has been well documented. Although established clinical guidelines suggest comprehensive lifestyle modification to induce weight loss, many patients do not respond to lifestyle interventions and may not qualify for bariatric surgery. For these patients, pharmacotherapy may serve as a therapeutic option. Several anti-obesity pharmacotherapies, such as phentermine, are indicated for short-term use and are not required to demonstrate clinically meaningful weight loss (i.e., ≥5%). For long-term weight management, the FDA has approved 5 agents so far-orlistat, lorcaserin, phentermine/topiramate, naltrexone/bupropion, and liraglutide. These drugs have shown efficacy in enabling patients to achieve cli...Continue Reading

References

Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Jul 19, 2006·Neuron·Lora K HeislerMichael A Cowley
Nov 17, 2007·BMJ : British Medical Journal·Diana RuckerDavid C W Lau
Nov 11, 2008·Obesity·Frank L GreenwayMichael A Cowley
Feb 4, 2010·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·D Withrow, D A Alter
Feb 16, 2010·Diabetes, Obesity & Metabolism·Ken Fujioka
Jul 22, 2010·The New England Journal of Medicine·Steven R SmithUNKNOWN Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group
Sep 8, 2010·The New England Journal of Medicine·W Philip T JamesUNKNOWN SCOUT Investigators
Jul 29, 2011·The Journal of Clinical Endocrinology and Metabolism·Meredith C FidlerUNKNOWN BLOSSOM Clinical Trial Group
Feb 4, 2012·Acta Pharmacologica Sinica·Zhi-yun Zhang, Ming-wei Wang
Mar 1, 2012·Diabetes & Metabolism Journal·Jun Goo Kang, Cheol-Young Park
Sep 19, 2012·International Journal of Surgical Oncology·Brian ShragerStephen C Ward
Apr 30, 2013·Expert Opinion on Drug Discovery·Gilbert W KimScott A Waldman
May 1, 2013·Drug Design, Development and Therapy·Gina CosentinoGabriel I Uwaifo
May 11, 2013·Circulation. Cardiovascular Imaging·Neil J WeissmanChristen M Anderson
Jun 4, 2013·Journal of Diabetes and Its Complications·Robert R HenryW Timothy Garvey
Jul 3, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·T A WaddenUNKNOWN NN8022-1923 Investigators
Nov 2, 2013·The Journal of Clinical Investigation·Eric D BerglundJoel K Elmquist
Dec 11, 2013·The Journal of Endocrinology·L van BloemendaalM Diamant
Feb 27, 2014·JAMA : the Journal of the American Medical Association·Cynthia L OgdenKatherine M Flegal
Mar 20, 2014·Annals of the New York Academy of Sciences·George A Bray, Donna H Ryan
Sep 4, 2014·JAMA : the Journal of the American Medical Association·Robert F Kushner, Donna H Ryan
Jan 16, 2015·The Journal of Clinical Endocrinology and Metabolism·Caroline M ApovianUNKNOWN Endocrine Society
Jul 3, 2015·The New England Journal of Medicine·Xavier Pi-SunyerUNKNOWN SCALE Obesity and Prediabetes NN8022-1839 Study Group

❮ Previous
Next ❯

Citations

Mar 8, 2016·The Journal of Antimicrobial Chemotherapy·Cristina GervasoniAgostino Riva
Dec 20, 2015·Metabolism: Clinical and Experimental·Hannah MathewChristos S Mantzoros
Apr 30, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A L JoãoR Fernandes
May 30, 2016·Trends in Pharmacological Sciences·Maite SolasJ Alfredo Martínez
Feb 26, 2016·The Journal of Endocrinology·Martina HolubováLenka Maletínská
Jul 16, 2016·The Journal of Endocrinology·Jaroslav KunešLenka Maletínská
Aug 30, 2016·Neuroscience and Biobehavioral Reviews·R J Rodgers
Feb 2, 2018·Postgraduate Medicine·Dhiren K Patel, Fatima Cody Stanford
Jan 19, 2018·Expert Review of Clinical Pharmacology·Julie Rask LarsenPeter Manu
Sep 7, 2017·American Journal of Physiology. Endocrinology and Metabolism·Matthias Van HulPatrice D Cani
Dec 14, 2017·Journal of Molecular Endocrinology·Martina HolubováBlanka Železná
Jan 23, 2019·Molecular Nutrition & Food Research·Xiaojun LiJinyou Duan
Mar 9, 2019·The American Journal of Gastroenterology·Deepinder GoyalUNKNOWN FDA-Related Matters Committee of the American College of Gastroenterology
May 18, 2016·Endocrine Reviews·Pieter StijnenJohn W M Creemers
Dec 18, 2018·Endocrine, Metabolic & Immune Disorders Drug Targets·Luciana ScottiMarcus Tullius Scotti
Aug 1, 2018·Expert Review of Endocrinology & Metabolism·Maria Letizia PetroniGiulio Marchesini
Oct 14, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Suriyan PonnusamyRamesh Narayanan
Jul 21, 2020·The Cochrane Database of Systematic Reviews·Agnes TullyFionnuala Jordan
Dec 3, 2015·Nutrition & Metabolism·Satoru SugimotoHajime Hosoi
Jun 29, 2016·World Journal of Gastroenterology : WJG·Seung Han KimYoon Tae Jeen
Dec 6, 2018·Nutrition & Dietetics : the Journal of the Dietitians Association of Australia·Ranil JayawardenaAndrew P Hills
Jun 21, 2017·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Vignesh ShettarSrividya Kidambi
Jun 23, 2018·Eating and Weight Disorders : EWD·Simona CalugiRiccardo Dalle Grave
Dec 15, 2015·American Journal of Lifestyle Medicine·Craig A Johnston, Jennette P Moreno
Jan 1, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Suriyan PonnusamyRamesh Narayanan
Apr 16, 2020·Anais Da Academia Brasileira De Ciências·Cristina M S LucasJosé Geraldo Mill
Aug 1, 2019·Cellular & Molecular Immunology·Tian-Yu LinYu-Hsiang Hsu
Apr 30, 2017·Current Hypertension Reports·Rohan SamsonSuzanne Oparil
Oct 6, 2018·BMC Obesity·Giliane BelarminoDan L Waitzberg
Jun 6, 2017·Diabetology & Metabolic Syndrome·Marcio C Mancini, Maria Edna de Melo
Mar 7, 2021·Nutrients·Vitor Jacó AntracoMaria Isabel Cardoso Alonso-Vale
Jul 8, 2021·Expert Review of Clinical Pharmacology·Dhiren Patel, April Smith
Aug 2, 2021·The Medical Journal of Australia·Dominic A StaudenmannAdrian Sartoretto
Oct 1, 2021·Archives of Endocrinology and Metabolism·Louise CominatoDurval Damiani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Arianne N SweetingTania P Markovic
Expert Opinion on Pharmacotherapy
Vojtech Hainer
European Journal of Internal Medicine
Ashish Kumar Kakkar, Neha Dahiya
© 2021 Meta ULC. All rights reserved